First-Line Treatment for Anxiety Disorders
For anxiety disorders, the recommended first-line treatments are selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and cognitive behavioral therapy (CBT), either as monotherapy or in combination. 1, 2
Pharmacological Treatment Options
- SSRIs (such as escitalopram, paroxetine, sertraline, and fluvoxamine) are suggested as first-line pharmacological treatment for anxiety disorders due to their efficacy and favorable side effect profile 1, 2
- Sertraline has demonstrated effectiveness for social anxiety disorder, panic disorder, and PTSD at doses of 50-200 mg/day 3
- Venlafaxine (an SNRI) is recommended as an alternative first-line medication when SSRIs are not tolerated or ineffective 1, 2
- Medication should be initiated at lower doses and gradually titrated to minimize initial anxiety/agitation that can occur with SSRIs 4
- After achieving remission, medications should be continued for 6-12 months to prevent relapse 5
Psychological Interventions
- Cognitive behavioral therapy (CBT) specifically developed for anxiety disorders is strongly recommended as a first-line treatment option 1, 2
- Individual CBT is preferred over group therapy due to superior clinical and economic effectiveness 1, 2
- CBT should be structured with approximately 14 sessions over 4 months, with each session lasting 60-90 minutes 1
- For patients who cannot or do not want face-to-face therapy, self-help with CBT-based support is a viable alternative 1
Treatment Algorithm
Step 1: Initial Treatment Selection
- Begin with either:
Step 2: Medication Management
- Start with lower doses of SSRIs to minimize initial side effects 4
- For sertraline, begin with 25-50 mg/day and titrate up to 50-200 mg/day based on response 3
- Allow 8 weeks to assess full medication effectiveness 2
Step 3: Treatment Adjustment
- If first SSRI is ineffective after adequate trial, consider:
Special Considerations
- Regular monitoring using standardized assessment tools is essential for evaluating treatment effectiveness 2
- Benzodiazepines, despite providing rapid anxiety relief, are not recommended for routine first-line use due to dependence potential 4
- Complete remission may not occur with the first medication trial; switching to another first-line agent may be necessary 4
- Anxiety disorders are chronic conditions that often require long-term treatment; premature discontinuation increases relapse risk 5, 7
Common Pitfalls to Avoid
- Underutilizing psychological interventions like CBT, which have strong evidence for effectiveness 2
- Using higher medication doses than necessary, which increases adverse effects without necessarily improving efficacy 4
- Discontinuing medication too soon after symptom improvement 5
- Failing to consider comorbid conditions that may influence treatment selection (e.g., depression, substance use disorders) 7